ParkinsonCanadaV1, Main, Exploration, bibRecord, 001473

ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE

Identifieur interne : 001473 ( Main/Exploration ); précédent : 001472; suivant : 001474

ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE

Auteurs : Alain Dagher [Canada]

Source :

Addiction [ 0965-2140 ] ; 2012-02.

RBID : ISTEX:844ADA97645835203357FEC9BB4E01464D3F99FC

English descriptors

KwdEn :
- Addiction, Antiparkinson Agents (adverse effects), Antiparkinson Agents (pharmacology), D1, D2, Dopamine Agents (adverse effects), Dopamine Agents (pharmacology), Humans, Levodopa (adverse effects), Levodopa (pharmacology), Parkinson Disease (drug therapy), Parkinson Disease (psychology), Parkinson's disease., Receptors, Dopamine (drug effects), Reinforcement (Psychology), Substance-Related Disorders (diagnosis), Substance-Related Disorders (etiology), Syndrome, dopamine, gambling, levodopa.
MESH :
- chemical , adverse effects : Antiparkinson Agents, Dopamine Agents, Levodopa.
- chemical , drug effects : Receptors, Dopamine.
- chemical , pharmacology : Antiparkinson Agents, Dopamine Agents, Levodopa.
- diagnosis : Substance-Related Disorders.
- drug therapy : Parkinson Disease.
- etiology : Substance-Related Disorders.
- psychology : Parkinson Disease.
- Humans, Reinforcement (Psychology), Syndrome.

Url:

https://api-v5.istex.fr/document/844ADA97645835203357FEC9BB4E01464D3F99FC/fulltext/pdf

DOI: 10.1111/j.1360-0443.2011.03624.x

Affiliations:

Canada

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE</title>
<author><name sortKey="Dagher, Alain" sort="Dagher, Alain" uniqKey="Dagher A" first="Alain" last="Dagher">Alain Dagher</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:844ADA97645835203357FEC9BB4E01464D3F99FC</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1111/j.1360-0443.2011.03624.x</idno>
<idno type="url">https://api-v5.istex.fr/document/844ADA97645835203357FEC9BB4E01464D3F99FC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000342</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000342</idno>
<idno type="wicri:Area/Istex/Curation">000342</idno>
<idno type="wicri:Area/Istex/Checkpoint">000320</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000320</idno>
<idno type="wicri:doubleKey">0965-2140:2012:Dagher A:addiction:as:aberrant</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:22248132</idno>
<idno type="wicri:Area/PubMed/Corpus">000B01</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B01</idno>
<idno type="wicri:Area/PubMed/Curation">000B01</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000B01</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000B01</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B01</idno>
<idno type="wicri:Area/Ncbi/Merge">001040</idno>
<idno type="wicri:Area/Ncbi/Curation">001040</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001040</idno>
<idno type="wicri:Area/Main/Merge">001505</idno>
<idno type="wicri:Area/Main/Curation">001473</idno>
<idno type="wicri:Area/Main/Exploration">001473</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE</title>
<author><name sortKey="Dagher, Alain" sort="Dagher, Alain" uniqKey="Dagher A" first="Alain" last="Dagher">Alain Dagher</name>
<affiliation wicri:level="1"><country wicri:rule="url">Canada</country>
<wicri:regionArea>Montreal Neurological Institute, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Addiction</title>
<idno type="ISSN">0965-2140</idno>
<idno type="eISSN">1360-0443</idno>
<imprint><publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2012-02">2012-02</date>
<biblScope unit="volume">107</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="248">248</biblScope>
<biblScope unit="page" to="250">250</biblScope>
</imprint>
<idno type="ISSN">0965-2140</idno>
</series>
<idno type="istex">844ADA97645835203357FEC9BB4E01464D3F99FC</idno>
<idno type="DOI">10.1111/j.1360-0443.2011.03624.x</idno>
<idno type="ArticleID">ADD3624</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0965-2140</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Addiction</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>D1</term>
<term>D2</term>
<term>Dopamine Agents (adverse effects)</term>
<term>Dopamine Agents (pharmacology)</term>
<term>Humans</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (pharmacology)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (psychology)</term>
<term>Parkinson's disease.</term>
<term>Receptors, Dopamine (drug effects)</term>
<term>Reinforcement (Psychology)</term>
<term>Substance-Related Disorders (diagnosis)</term>
<term>Substance-Related Disorders (etiology)</term>
<term>Syndrome</term>
<term>dopamine</term>
<term>gambling</term>
<term>levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptors, Dopamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Reinforcement (Psychology)</term>
<term>Syndrome</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Dagher, Alain" sort="Dagher, Alain" uniqKey="Dagher A" first="Alain" last="Dagher">Alain Dagher</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001473 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001473 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:844ADA97645835203357FEC9BB4E01464D3F99FC
   |texte=   ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE

ADDICTION AS ABERRANT LEARNING—EVIDENCE FROM PARKINSON'S DISEASE

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.